XPhyto Therapeutics (CSE: XPHY – OTC: XPHYF) CEO Hugh Roger joined Steve Darling from Proactive to bring news the company has signed a master supply agreement with the operator of 10 COVID-19 test centres In Germany.
Rogers telling Proactive the delivery of 1,000 Covid-ID Lab tests to test centres in Berlin will begin this week and will kick off a short trial period to integrate and evaluate this new PCR test system.